Get Full Government Meeting Transcripts, Videos, & Alerts Forever!
Get email alerts on the Drug Policy topic
No spam. Unsubscribe anytime.
Utah House passes bill to license and track drug-precursor sales, adopts amendment narrowing scope
Summary
The Utah House passed House Bill 58 on Jan. 30, 1992, requiring licensing and periodic reporting of controlled-precursor sales and creating a five-member advisory board; members adopted an amendment clarifying that naturally occurring amounts are not covered.
The Utah House of Representatives on Jan. 30 approved House Bill 58, a measure that would require sellers and purchasers of certain controlled-substance precursor chemicals to be licensed by the Department of Commerce and to report sales periodically. Representative Jensen, the bill sponsor, told members the idea originated in a ninth-grade civics class and was refined by the attorney general’s office.
The bill establishes a five-member advisory board to help set licensing rules and includes sellers and distributors among the board’s membership. Jensen said the measure “will not stop that sale, but it will allow us to track who is making the purchase,” describing the proposal as a tool to help trace precursors used in illegal drug manufacture.
During floor debate, Representative Valentine moved pink-sheet amendments to clarify that items such as encapsulated vitamins or dietary supplements with small, naturally occurring amounts of listed chemicals would not be subject to the licensing requirement. After questions from Representative Harwood and discussion about the phrase “naturally occurring insignificant amounts,” Representative Valentine amended his own motion to remove the word “insignificant” so the language would read “may contain naturally occurring amounts.” The House adopted that amendment and then passed the bill by recorded vote.
The roll-call recorded 72 affirmative votes and zero negative votes. The bill, as amended, will be forwarded to the Senate for further consideration.
The bill’s sponsor and supporters framed it as a public-safety measure that preserves legitimate commercial uses of listed chemicals while giving state regulators and law enforcement a way to trace suspicious purchases. Opponents raised concerns about potential burdens on small businesses; members agreed to an advisory-board structure and the clarified exclusion for naturally occurring amounts to address those concerns.
Next steps: The House sent the amended bill to the Senate for its consideration.
